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DISPATCHES
Helle Brander Eriksen, Heidi Gumpert,  
Cecilie Haase Faurholt, Henrik Westh
In a hospital-acquired infection with multidrug-resistant 
Elizabethkingia, matrix-assisted laser desorption/ioniza-
tion time-of-flight mass spectrometry and 16S rRNA gene 
analysis identified the pathogen as Elizabethkingia miri-
cola. Whole-genome sequencing, genus-level core ge-
nome analysis, and in silico DNA-DNA hybridization of 35 
Elizabethkingia strains indicated that the species taxonomy 
should be further explored.
Elizabethkingia are gram-negative, nonmotile, non-spore-forming rods that are rarely associated with 
human disease. E. meningoseptica is the most recognized 
clinically, mainly causing hospital-acquired infections, in-
cluding sepsis in immunocompromised patients and men-
ingitis in neonates (1). These bacteria are intrinsically resis-
tant to β-lactam antimicrobial drugs, including second- and 
third-generation cephalosporins and carbapenems, because 
they naturally carry an Ambler class A serine β-lactamase 
gene bla
CME
, which encodes a penicillin- and cephalospo-
rin-hydrolyzing enzyme (2), and 2 Ambler class B metallo-
β-lactamase genes, blaB and blaGOB, which encode carbape-
nem-hydrolyzing enzymes (3). 
The species E. anopheles and E. miricola are in-
creasingly being isolated and cause similar infections to 
E. meningoseptica (4,5). E. miricola was discovered in 
condensed water collected onboard the Russian space 
station Mir in 2003 (6), and E. anopheles was isolated 
from the midgut of the Anopheles gambiae mosquito in 
2011 (7). We report infection with a carbapenem-resistant 
Elizabethkingia species in a patient in Copenhagen, Den-
mark in September 2015; we identified the bacterium as 
E. miricola by using MALDI-TOF (matrix-assisted laser 
desorption/ionization time-of-flight) mass spectrometry. 
We further studied the isolate using whole-genome se-
quencing (WGS) and compared it with other available 
Elizabethkingia genomes.
The Study
The patient was a 64-year-old man with recurrent erysip-
elas of both legs. He was initially hospitalized with erysip-
elas in August 2015 and successfully treated with penicillin 
and dicloxacillin. On readmission in September 2015, he 
was again treated with intravenous penicillin and dicloxa-
cillin. Six days later, the patient felt increased pain, and 
his knee became warm and sore. These findings were in-
terpreted to be symptoms of reactive arthritis caused by a 
urinary tract infection, and his drug treatment was changed 
to cefuroxime. The following day, a cloudy synovial fluid 
was aspired from his knee, so ciprofloxacin was added to 
his drug regimen. Because of aggravating symptoms and 
increasing C-reactive protein levels, the patient’s treatment 
was then changed to piperacillin with tazobactam, after 
which his symptoms improved. The patient was discharged 
with oral dicloxacillin and ciprofloxacin, and 4 weeks later 
he was well.
An overnight culture of the synovial fluid from the pa-
tient’s knee grew multidrug-resistant, gram-negative, non-
motile rods. MALDI-TOF (MALDI Biotyper 3.1, Bruker 
Daltonics Microflex LT, database MBT DB-5627) identi-
fied the colonies as E. miricola (score 2.105). Antimicrobi-
al susceptibility testing showed that the isolate was suscep-
tible to ciprofloxacin (MIC 0.25 mg/L) and co-trimoxazole 
(MIC 0.125 mg/L); intermediately susceptible to piperacil-
lin/tazobactam (MIC 16 mg/L), amoxicillin/clavulanic acid 
(MIC 8 mg/L), and tigecycline (MIC 0.5 mg/L); and resis-
tant to all other drugs tested (Table). The imipenem/imipe-
nem-EDTA Etest (bioMérieux, Marcy l’Etoile, France) for 
detection of metallo-β-lactamase was positive.
To confirm the species identity and identify the antimi-
crobial resistance genes, we performed WGS of the isolate 
with the Illumina MiSeq platform producing 2 × 150-bp 
paired-end reads by using the Nextera XT library prepara-
tion kit (Illumina Denmark ApS, Copenhagen, Denmark). 
Reads were assembled by using SPAdes, which produced 
a 4.13-Mbp genome termed HvH-WGS333 (BioProject 
PRJNA335686, BioSample SAMN05450241). We per-
formed annotation of the genome using Prokka (8) and 
used ARG-ANNOT (9) to identify 2 metallo-β-lactamase 
genes, namely blaB-4 and blaGOB-13, and an extended-spec-
trum β-lactamase gene sharing 90.6% nucleotide identity 
with bla
CME-1
. The isolate was identified by EzTaxon (10) as 
E. miricola on the basis of its 16S rRNA gene with 99.69% 
similarity. However, single-nucleotide variant (SNV) 
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analysis by read alignment with Bowtie2 and SNV-calling 
with SAMtools comparing HvH-WGS333 and the GTC 
862 E. miricola strain (accession no. NZ_LSGQ00000000) 
yielded ≈78,000 SNVs. Furthermore, analyzing the cover-
age breadth by using BEDTools revealed that this isolate 
shared 80.5% of this E. miricola genome.
Because the isolate from this patient was not closely 
related to the E. miricola type strain, we performed a ge-
nus-level core genome analysis of 35 publicly deposited 
Elizabethkingia strains from GenBank to identify a more 
closely related isolate. Each genome was annotated (8) and 
the core genome was approximated by ROARY (11), yield-
ing a 419,813-bp core genome of 426 genes. We construct-
ed a phylogenetic tree of the core genome using RAxML 
(12) with 100 bootstrapping replicates (Figure). The ATCC 
13253 E. meningoseptica strain did not cluster with the 
other E. meningoseptica strains and was the most distantly 
related Elizabethkingia sp. analyzed. Before WGS was 
commonly used, high levels of divergence were reported 
among E. meningoseptica (formerly Flavobacterium me-
ningosepticum) isolates, with 2 groups detected, Ursing and 
Bruun (UB) I and UBII (13), with ATCC 13253 belonging 
to UBI. Our HvH-WGS333 isolate was most closely re-
lated to EM_CHUV, an endotracheal isolate submitted as 
E. miricola; these 2 isolates are next most closely related to 
G4071, which belongs to the UBII:2 (13), and then to GTC 
862 E. miricola. E. miricola ATCC 33958 is most closely 
related to G4075, a clinical blood culture E. meningosep-
tica in the UBII:3 group. Strains belonging to groups UBI 
and UBII are phenotypically very similar, explaining why 
DNA-DNA hybridization (DDH) was previously used to 
distinguish these groups (14).
Additionally, we performed in silico DDH (15) to oth-
er sequenced Elizabethkingia isolates to determine whether 
our isolate could be defined as the same species (i.e., having 
a DDH value >70%). The in silico DDH value is calcu-
lated by summing up the identities in matches between 
the genome sequences and dividing by the total match hit 
lengths. HvH-WGS333 only had an in silico DDH >70% 
with EM_CHUV and G4071, which clustered most closely 
together in the tree but was also closely related (67.1%) to 
strain GTC 862 (Figure). A previous DDH study investigat-
ing the Elizabethkingia genus found DDH values at 70°C of 
52% between UBII:2 and UBII:3, 45% between UBII:2 and 
UBII:4, and 36% between UBII:3 and UBII:4 (14), in agree-
ment with our in silico DDH results (Figure). Our analyses 
support the identification of the 3 UBII subgroups 2, 3, and 
4 as being 3 different Elizabethkingia species, with UBII:2 
being the closest related to the E. miricola type strain.
Conclusions
The wide adoption of MALDI-TOF mass spectrometry for 
bacterial identification is likely to increase the detection of 
infections caused by Elizabethkingia, and thus the number 
of infection reports. However, the applied MALDI-TOF 
database contained only 3 E. meningoseptica and 1 E. miri-
cola isolates at the time of our study. Identification on the 
basis of the 16S rRNA gene corroborated our MALDI-TOF 
mass spectrometry identification of E. miricola. When ex-
ploring this further using WGS, we discovered our isolate 
shared 80.5% of the GTC 862 E. miricola genome and the 
in silico DDH value was 67.1%, just below the 70% spe-
cies threshold. It thus appears that our isolate, along with 
EM_CHUV and G4071, is closely related to the E. miri-
cola species and that the taxonomic position of the UBII:3 
and UBI:4 strains should be reconsidered. In light of our 
WGS analysis demonstrating considerable Elizabethkingia 
genetic diversity, we suggest that the MALDI-TOF data-
base needs to be updated and the nomenclature needs to be 
re-examined. WGS is proving to be a valuable tool for the 
 
 
 
Table. Antimicrobial susceptibility of Elizabethkingia isolate HvH-WGS333 from patient with hospital-acquired septic arthritis, 
Copenhagen, Denmark 2015* 
Antimicrobial MIC, mg/L MIC breakpoint, S≤/R>, mg/L Interpretation 
Ciprofloxacin 0.25 0.5/1 Susceptible 
Co-trimoxazole 0.125 4/4 Susceptible 
Tigecycline 0.5 0.25/0.5  Intermediate 
Piperacillin/tazobactam† 16 4/16 Intermediate 
Amoxicillin/clavulanic acid‡ 8 2/8 Intermediate 
Ampicillin >256 2/8 Resistant 
Cefuroxime >256 4/8 Resistant 
Ceftazidime >256 4/8 Resistant 
Meropenem >32 2/8 Resistant 
Gentamicin 12 4/4 Resistant 
Colistin >256 4/4 Resistant 
*Submitted isolate to GenBank (accession no. NZ_MCJF00000000.1). The isolate contains antimicrobial resistance genes blaB-4, blaGOB-13, and an 
extended-spectrum β-lactamase, sharing 90.6% nucleotide identity to blaCME-1. Antimicrobial susceptibility testing was performed by using Etest 
(bioMérieux, Marcy l’Etoile, France) according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines 
(http://www.eucast.org). For interpretation, non–species-related (pharmacokinetics/pharmacodynamics) breakpoints were used except for co-trimoxazole, 
in which Stenotrophomonas malthophilia breakpoints were used, and for gentamicin and colistin, in which Pseudomonas sp. breakpoints were used. R, 
resistance; S, susceptibility. 
†For susceptibility testing purposes, the concentration of tazobactam was fixed at 4 mg/L.  
‡For susceptibility testing purposes, the concentration of clavulanic acid was fixed at 2 mg/L. 
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correct identification of new species and detailed character-
ization of multidrug-resistant bacteria.
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Microbiology and is affiliated with the Department of Clinical  
Microbiology, Copenhagen University Hospital, Hvidovre,  
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